Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
It can activate the division and migration of epidermal cells, promote the repair and regeneration of damaged tissues, and accelerate wound healing
Whether you're recovering from an injury, managing a chronic condition, or simply want to feel your best, our team is here to guide you every step of the way
The drug development pipeline for 2025 looks promising, with several new medications set to hit pharmacy shelves
Over time, this rewiring produces lasting changes in food preferences
In the first of several votes, the panel of Food and Drug Administration experts narrowly voted 8-6 in favor of broadening access to a chemical called BPC-157, one of the most popular peptides among longevity and wellness influencers